TABLE 3.
Rare variants in AD-risk gene TREM2 identified in this study.
ID patient | FH score | Nucleotide change | Protein change | Pathogenicity ClinVar/HGMD | Clinical classification | Frequency GnomAD (EU)1 |
P-value2 |
AD#085 | 0 | c.140G > A | p.Arg47His | Likely benign/Alzheimer disease, increased risk | Risk factor | 315/127748 | 0.18 |
AD#026 | 3 | c.287C > A | p.Thr96Lys | Benign/frontotemporal dementia, increased risk | Risk factor | 130/129182 | 0.08 |
c.632T > C | p.Leu211Pro | Benign/Alzheimer disease, increased risk | Risk factor | 144/129164 | 0.11 | ||
AD#045 | 0 | c.407G > A | p.Arg136Gln | Uncertain significance/Alzheimer disease? | Risk factor | 17/128820 | 0.02 |
AD#089 | 3.5 | c.668C > T | p.Thr223Ile | Benign/Alzheimer disease? | Risk factor | 49/129176 | 0.05 |
AD, Alzheimer disease, FH, family history. 1Population allele frequencies referred to the European (non-Finnish) population reported on GnomAD v2.1.1, expressed as Allele count (Alt/total). 2P-value Fisher’s exact test, BH correction.